Insight Molecular Diagnostics Inc. Common Stock
Symbol: IMDX (NASDAQ)
3.20
▲ (6.67%) 0.200
Company Description:
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.
Key Stats
- Today's Open: $2.94
- Today's High: $3.255
- Today's Low: $2.705
- Today's Volume: 83.28K
- Yesterday Close: $3
- Yesterday High: $3.1
- Yesterday Low: $2.6
- Yesterday Volume: 46.47K
- Last Min Volume: 1
- Last Min High: $3.2
- Last Min Low: $3.2
- Last Min VWAP: $3.2
Company Profile
- Name: Insight Molecular Diagnostics Inc. Common Stock
- Website: https://www.imdxinc.com
- Listed Date: 2015-12-30
- Location: NASHVILLE, TN
- Market Status: Active
- CIK Number: 0001642380
- SIC Code: 2835
- SIC description: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Market Cap: $85.86M
- Round Lot: 100
- Outstanding Shares: 28.62M
- Asset Type: CS
RECENT FILINGS FOR IMDX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-18 | S-8 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-02 | 8-K | View |
| 2025-06-17 | 8-K | View |
| 2025-05-14 | ARS | View |
| 2025-05-14 | DEFA14A | View |
| 2025-05-14 | DEF 14A | View |
| 2025-05-12 | 10-Q | View |
| 2025-05-12 | 8-K | View |
| 2025-05-09 | SCHEDULE 13G/A | View |
| 2025-04-17 | 8-K | View |
| 2025-04-08 | 424B3 | View |
| 2025-04-07 | EFFECT | View |
| 2025-04-04 | CORRESP | View |
| 2025-04-03 | UPLOAD | View |
| 2025-03-28 | S-1 | View |